AOD-9604: The Peptide That Speeds Up Stubborn Abdominal Fat Loss by Up to 17%

AOD-9604 is one of the few orally active peptides. It is derived from hGH and has proven efficiency in fat burning. Unlike many other fat-burning peptides or growth hormones, it doesn’t increase blood sugar. While hGH has a high chance of causing joint swelling and putting pressure on pancreatic functions like insulin secretion, AOD-9604 has proven results showing fewer side effects of that nature.

Use of AOD-9604: Get Safe, Focused Fat Loss Results from Every Single Dose

If you are living with diabetes and trying to lose weight, AOD-9604 is a unique medical option worth knowing about. This treatment is a tiny, engineered piece of natural growth hormone that focuses entirely on burning stubborn fat and stopping your body from storing new fat cells. The biggest benefit for anyone with diabetes is that it does its job without affecting your blood sugar or insulin levels at all.

Traditional growth hormones often cause dangerous blood sugar spikes and painful joint swelling. In contrast AOD-9604 specialized version completely bypasses those problems. As a fat loose peptide, AOD-9604 offers a much safer, gentler way to jumpstart your weight loss journey without putting extra stress on your pancreas.

• Promoting Lipolysis (Fat Breakdown): It stimulates the destruction and release of stored fat from adipose tissue, particularly targeting stubborn visceral fat.
• Inhibiting Lipogenesis (Fat Storage): It blocks the metabolic pathways that convert excess non-fatty foods and carbohydrates into new body fat cells.
• Weight Management Without Insulin Interference: It is used to support weight loss without raising blood sugar levels or stressing the pancreas with excess insulin secretion.
• Cartilage and Joint Repair: It is used in regenerative medicine to promote the healing of damaged cartilage, often showing positive results in treating osteoarthritis.
• Reducing Joint Pain and Inflammation: When applied to damaged joints, it helps lower localized inflammation and aids in cellular recovery.
• Safer Alternative to Full hGH: It provides the metabolic and regenerative benefits of human growth hormone without causing unwanted side effects like water retention or joint swelling.

Price of AOD-9604 (Pinnacle Peptide Labs)

When you source from Pinnacle Peptide Labs, you are investing in the gold standard of laboratory reagents. Every single vial of our AOD-9604 [5MG] is proudly produced, verified, and fulfilled right here from our U.S.-based lab, guaranteeing swift turnaround times and elite quality control. By utilizing advanced lyophilization for maximum compound stability and verifying every batch to a strict ≥ 99% HPLC purity standard, we provide researchers with the repeatable handling and consistent results required for critical metabolic models.

Quantity (Vials)	Price Per Vial	Your Savings
1 – 5	$64.99	Standard Value
6 – 10	$61.74	Save 5%
11 – 15	$58.49	Save 10%
16 – 20	$55.24	Save 15%
21+	$51.99	Save 20% (Best Value)

The Key Benefits of AOD-9604 in Fat and Metabolism Research

AOD-9604 is a special piece of the human growth hormone. Scientists use it to study how the body handles fat. The best part? It does the helpful stuff without causing the problems that come with the full hormone.

• It Helps Burn Stubborn Fat AOD-9604 tells the body to break down fat, especially the hard-to-lose fat stored around the belly. At the same time, it leaves muscle alone.
• It Stops the Body From Making New Fat– AOD-9604 can block the process the body uses to turn extra food and sugar into stored fat.
• It Doesn’t Mess With Blood Sugar Regular growth hormones can raise blood sugar levels, but AOD-9604 doesn’t. This makes it really useful for studying conditions like metabolic syndrome, where blood sugar and fat are already a problem.
• It Doesn’t Cause the Bad Side Effects of Growth Hormones Since AOD-9604 doesn’t connect to the same receptors as regular growth hormones, it won’t cause things like swollen joints, water retention, or organ problems.
• It May Help Repair Joints – Research also shows AOD-9604 might help the body rebuild cartilage, which is the soft tissue that cushions your joints.
• It’s Easy to Work With in a Lab – AOD-9604 comes in a dry, powder form that stays stable for a long time. This means scientists can measure it accurately and get the same results over and over again.

How AOD-9604 Works?

AOD-9604 is a small peptide fragment taken from the tail end of human growth hormone (HGH). It was specifically designed to copy HGH’s fat-burning ability — without triggering the growth-related effects that make full HGH problematic.

The key difference is that AOD-9604 does not bind to the growth hormone receptor (GHR). This means it skips the chain reaction that normally causes IGF-1 production, tissue growth, and insulin resistance. Instead, it is proposed to work through a separate pathway — likely by stimulating beta-3 adrenergic receptors on fat cells. This activates an enzyme called hormone-sensitive lipase (HSL), which breaks down stored triglycerides and releases free fatty acids to be burned for energy.

On top of that, AOD-9604 may also block lipogenesis — the process the body uses to convert excess calories into new fat. So it works on both ends: promoting fat breakdown while slowing new fat creation.

A secondary area of interest is cartilage and bone. Phase 2 trial data from Pathway Therapeutics suggests AOD-9604 may support cartilage repair in osteoarthritis patients, though the exact mechanism here is not yet fully understood.

Clinical Evidence

AOD-9604 has completed Phase 1 and Phase 2 clinical trials. Phase 3 was never pursued for its original obesity indication. The results of second phase is quite more impressive.

Phase 1 confirmed a clean short-term safety profile in healthy volunteers — no serious adverse events, no antibody formation, no effect on blood glucose or IGF-1.

While the Phase 2 (Obesity) tested oral doses ranging from 1 mg to 20 mg daily. Some early analysis showed statistically significant weight loss versus placebo at certain doses. However, development for obesity was ultimately discontinued — and the evidence behind it is weak. Notably, Dr. Edwin Lee, an endocrinologist who appeared in support of AOD-9604 at the December 2024 PCAC meeting, explicitly stated that AOD-9604 “was ineffective for weight loss” and “should not be considered as a weight loss peptide.”

Phase 2 (Osteoarthritis) conducted by Pathway Therapeutics tested intra-articular (direct joint) injections in osteoarthritis patients. Results showed improvements in cartilage markers and patient-reported outcomes. This is now considered the more scientifically credible application for the compound.

FDA GRAS Determination confirmed AOD-9604 is safe for oral use as a food ingredient — but this is a safety assessment only, not evidence of therapeutic efficacy.

Bottom line on evidence quality:

• Safety: Solid — supported by Phase 1–2 data and GRAS determination
• Fat loss efficacy: Weak to none — not supported by Phase 2/3 and explicitly called out as ineffective by a clinical advocate
• Cartilage/joint efficacy: Early positive signal — Phase 2 data exists; Phase 3 confirmation still needed

Safety & Side Effects

AOD-9604 has a notably favorable short-term safety profile compared to most research peptides, backed by completed clinical trial data.

Confirmed in clinical trials:

• No effect on blood glucose or insulin sensitivity. This is a major advantage over full HGH therapy
• No elevation of IGF-1 — eliminates concerns about tissue overgrowth and related cancer risk
• No antibody formation detected — suggesting low immunogenicity based on human data
• No serious adverse events attributable to AOD-9604 across Phase 1–2 trials
• No significant differences from placebo in blood sugar, cortisol, heart disease markers, or stress response parameters

Commonly reported mild effects:

• Injection site redness, swelling, or discomfort (most common)
• Mild, transient fatigue or lethargy
• Occasional mild headache
• Mild nausea (uncommon)

Oral administration (based on Phase 2 trials at 1–20 mg/day) was generally well tolerated across all dose levels tested.

Important caveat: Despite the clean short-term profile, large-scale and long-term human safety data remain limited. This was a core part of the PCAC’s stated rationale for voting against Category 1 compounding in December 2024.

Contraindications

There is no official FDA drug label for AOD-9604. The following is based on clinical trial exclusion criteria and known pharmacological properties.

Avoid entirely:

• Athletes subject to WADA/USADA anti-doping rules — The World Anti-Doping Agency (WADA) prohibits AOD-9604 under Section S2 (Peptide Hormones and Growth Factors) or Section S0 (Non-Approved Substances). This ban creates an absolute contraindication for any tested athlete.
• Pregnancy and breastfeeding — Researchers lack adequate safety data on this compound; therefore, medical professionals do not recommend its use.
• Known hypersensitivity to AOD-9604 or any component of the formulation.

Use with caution:

• Active malignancy — AOD-9604 does not raise IGF-1 (unlike full HGH), but its pro-lipolytic and metabolic effects in cancer patients have not been studied.
• Children — Not studied in pediatric populations; not recommended.
• Patients with pituitary disorders — GH-fragment activity may interact with pituitary function in unpredictable ways.

What is notably NOT a contraindication — unlike full HGH therapy:

• Diabetes — AOD-9604 does not impair insulin sensitivity or raise blood glucose, confirmed in clinical trials.
• IGF-1-sensitive conditions — AOD-9604 does not stimulate IGF-1 production.

These absences are genuine, clinically supported advantages over full growth hormone therapy.

Order AOD-9604 Now!

Pinnacle Peptide Labs supplies AOD-9604 as a lyophilized powder for research use only. Pinnacle Peptide Labs manufacture each vial to strict quality standards to ensure accurate dosing and reliable results.

Order AOD-9604 from Pinnacle Peptide Labs →

Check Out Our Other High-Purity Peptides from the Best Manufacturers

Retatrutide

Semaglutide

Angiotensin II

Disclaimer about AOD-9604

This content about AOD-9604 is for informational and educational purposes only, is not medical advice, does not replace consultation with a licensed healthcare professional, and affiliate links may result in compensation at no additional cost to you.